NCT05098210
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Bronchial Neoplasms, Carcinoma, Bronchogenic, +46 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Unresectable Cutaneous Melanoma
Explore clinical trials studying Unresectable Cutaneous Melanoma. Study availability and eligibility vary by location and protocol.
6 public trials
3 recruiting studies
Unresectable Cutaneous Melanoma trial results
NCT06265285
- Conditions
- Adenocarcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, +81 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT07155317
- Conditions
- Advanced Acral Melanoma, Advanced Cutaneous Melanoma, Advanced Mucosal Melanoma, +19 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
Not Yet Recruiting
Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma
NCT07631325
- Conditions
- Unresectable Cutaneous Melanoma
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Not Yet Recruiting
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
NCT07576725
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
- Locations
-
- Uganda Cancer Institute Kampala, Uganda
NCT03033576
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, +3 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States